Funding Cuts in Denmark Threaten Bohr Institute

COPENHAGEN—Government cut-backs have jeopardized the survival of one of Europe’s oldest and most prestigious research centers. The Niels Bohr Institute, named in honor of the Danish pioneer of quantum theory, “will die out totally if we continue to lose permanent positions at the present rate,” said its director, Knud Hansen. “We simply cannot finance research posts for new, young scientists to replace those who are leaving through retirement and to take jobs ov

Written byBernard Dixon
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

COPENHAGEN—Government cut-backs have jeopardized the survival of one of Europe’s oldest and most prestigious research centers.

The Niels Bohr Institute, named in honor of the Danish pioneer of quantum theory, “will die out totally if we continue to lose permanent positions at the present rate,” said its director, Knud Hansen. “We simply cannot finance research posts for new, young scientists to replace those who are leaving through retirement and to take jobs overseas, particularly in the United States.”

Niels Bohr became the first director of his institute in 1918, when he returned to Copenhagen following four years of work with Lord Rutherford in Manchester, England. Bohr received the Nobel Prize for physics in 1922 and was involved in the Manhattan Project after fleeing occupied Denmark in 1943. His institute, which is closely affiliated with the University of Copenhagen, quickly became a mecca for physicists from through-out the world.

Although it ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies